Shattuck Labs, Inc.
General ticker "STTK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $343.6M (TTM average)
Shattuck Labs, Inc. follows the US Stock Market performance with the rate: 45.4%.
Estimated limits based on current volatility of 4.5%: low 6.72$, high 7.35$
Factors to consider:
- Total employees count: 40 (-9.1%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operational and conduct risks, Regulatory and compliance, Significant losses, Market competition, Economic downturns and volatility
- Current price 30.6% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.80$, 5.29$]
- 2026-12-31 to 2027-12-31 estimated range: [1.44$, 4.24$]
Financial Metrics affecting the STTK estimates:
- Positive: with PPE of -4.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -16.94 <= 0.28
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term STTK quotes
Long-term STTK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.66MM | $5.72MM | $1.00MM |
| Operating Expenses | $93.61MM | $86.29MM | $52.51MM |
| Operating Income | $-91.96MM | $-80.57MM | $-51.51MM |
| Non-Operating Income | $4.66MM | $5.16MM | $2.70MM |
| R&D Expense | $74.31MM | $67.21MM | $35.27MM |
| Income(Loss) | $-87.30MM | $-75.41MM | $-48.81MM |
| Net Income(Loss)* | $-87.30MM | $-75.41MM | $-48.81MM |
| Stockholders Equity | $144.71MM | $79.63MM | $82.39MM |
| Assets | $159.56MM | $91.05MM | $91.03MM |
| Operating Cash Flow | $-81.23MM | $-60.52MM | $-39.88MM |
| Capital expenditure | $0.41MM | $0.06MM | $0.07MM |
| Investing Cash Flow | $110.86MM | $-8.51MM | $-7.89MM |
| Financing Cash Flow | $48.62MM | $0.79MM | $44.57MM |
| Earnings Per Share** | $-2.05 | $-1.49 | $-0.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.